Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3701
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy ; volume:13 ; number:1 ; day:24 ; month:1 ; year:2023 ; pages:1-16 ; date:12.2023
Cell & bioscience ; 13, Heft 1 (24.1.2023), 1-16, 12.2023
- Urheber
-
Hwang, Sohyun
Lim, Jaejoon
Kang, Haeyoun
Jeong, Ju-Yeon
Joung, Je-Gun
Heo, Jinhyung
Jung, Daun
Cho, Kyunggi
An, Hee Jung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13578-023-00961-4
- URN
-
urn:nbn:de:101:1-2023033121194325238161
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hwang, Sohyun
- Lim, Jaejoon
- Kang, Haeyoun
- Jeong, Ju-Yeon
- Joung, Je-Gun
- Heo, Jinhyung
- Jung, Daun
- Cho, Kyunggi
- An, Hee Jung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Natural killer cell immunotherapy in glioblastoma
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Activated Natural Killer Cells Hit Neurogenesis in the Aging Brain
Natural killer cell immunotherapy in glioblastoma
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Activated Natural Killer Cells Hit Neurogenesis in the Aging Brain
Natural killer cell immunotherapy in glioblastoma
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy